Cargando…
Severe sinus bradycardia associated with favipiravir in a COVID‐19 patient
The antiviral medication “favipiravir” should be considered as a possible cause of unexplained sinus bradycardia.
Autores principales: | Habib, Mhd Baraa, Elshafei, Mohamed, Rahhal, Alaa, Mohamed, Mouhand F. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346599/ https://www.ncbi.nlm.nih.gov/pubmed/34401155 http://dx.doi.org/10.1002/ccr3.4566 |
Ejemplares similares
-
SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
Bronchopleural fistula causing persistent pneumothorax in COVID‐19 pneumonia patient with no risk factors
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022) -
Pheochromocytoma presenting with severe abdominal pain and abnormal liver enzymes
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
COVID-19 Pneumonia Complicated by Seizure Due to Severe Hyponatremia
por: Habib, Mhd Baraa, et al.
Publicado: (2021)